Effects of ankylosing spondylitis on cardiovascular disease: aMendelian randomization study
Authors:
Open Access
- 26 June 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 15, 1359829
Abstract
Objective: Accumulating evidence suggests that patients with ankylosing spondylitis (AS) have an elevated risk for cardiovascular disease (CVD) and cardiovascular death, however, whether AS has causal effects on the risk of CVD is unclear.Two-sample Mendelian randomization (MR) was utilizedto examine the probable causal link between them.Methods: Summary statistics from publicly released genome-wide association studies (GWAS) was used to perform MR analyses. Genetically predicted AS was selected as the exposure variable from published GWAS meta-analyses. CVD was adopted as the outcome variable. The inverse variant weighted method was employed to obtain the casual estimates. The robustness of the results was also examined by evaluating the pleiotropy and heterogeneity of single-nucleotide polymorphisms.Results: According to MR analyses, genetic susceptibility to AS was associated with a high risk of heart failure and ischemic stroke, while negativelygenetic susceptibility was found between AS and peripheral atherosclerosis. No statistical relationship was found between AS and venous thromboembolism, atrial fibrillation, coronary atherosclerosis, and valvular heart disease. Sensitivity analysis showed no evidence of horizontal pleiotropy or heterogeneity.Conclusion: The present study suggests that AS exerts causal effects on the risk of CVD, including heart failure, ischemic stroke, and peripheral atherosclerosis.Keywords
This publication has 40 references indexed in Scilit:
- Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two‐sample Mendelian randomization studyInternational Journal of Cancer, 2020
- Meta‐analysis andMendelianrandomization: A reviewResearch Synthesis Methods, 2019
- Ischemic stroke associated with ankylosing spondylitis: an integral part of disease spectrum, or a natural consequence of progressive infirmity?Acta Neurochirurgica, 2018
- Ischemic heart disease and ankylosing spondylitis—assessing the role of inflammationClinical Rheumatology, 2018
- Association of ischemic stroke with ankylosing spondylitis: a nationwide longitudinal cohort studyActa Neurochirurgica, 2018
- Oxidized low-density lipoprotein promotes osteoclast differentiation from CD68 positive mononuclear cells by regulating HMGB1 releaseBiochemical and Biophysical Research Communications, 2018
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- Secondary amyloidosis in ankylosing spondylitisRheumatology International, 2013
- Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population‐based studyArthritis & Rheumatism, 2011
- Population‐based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitisArthritis Care & Research, 2011